Celegence – Medical Alley Association

Celegence

MDR Article 117: Implications for Drug-device Combination Products

Manufacturers of combination products should seek regulatory advice and operational support from the expert Celegence team to ensure that essential documentation and clinical evidence for your product portfolio complies under the new MDR. To discuss how our team can strategically partner with yours, reach out to us at info@celegence.com, contact us online or read more about Celegence’s medical device […]

Regulatory Challenges in Writing EU MDR Compliant Clinical Evaluation Reports (CERs): What the Changes Could Mean for Your Products

This is the seventh in a series of blogs related to some of the key challenges being encountered to the recent updates to EU MDR. The New EU MDR Guidelines The new EU MDR guidelines will involve a lengthy EU MDR checklist including an array of topics, ranging from general administrative information to verification and validation, amongst […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER